Knee Brace and Biomechanical Footwear in the Treatment of Knee Osteoarthritis.
NCT ID: NCT03684850
Last Updated: 2020-01-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
120 participants
INTERVENTIONAL
2016-12-31
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Wedged Orthoses and Knee Osteoarthritis
NCT00420147
Footwear and Exercise for Knee Osteoarthritis (FiREwORK Trial)
NCT03796832
The Effect of Training With Custom-Made Biomechanical Perturbation Platform on Kinetics, Kinematics and Electromyography in Knee Osteoarthritis Patients
NCT00724139
Study of How An Ankle Strap Changes Effects of Insole Treatment for Knee Osteoarthritis
NCT00331110
Effect of Footwear on the Clinical, Functional, and Biomechanical Aspects in Elderly Women With Knee Osteoarthritis (OA)
NCT01342458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The subjects (n = 120) will be randomized into three groups mentioned above, after which they will start to do exercises, or to use a knee brace and do exercises, or to use biomechanical footwear at home according to the instructions for 4 months. Physical function, symptoms and quality of life will be measured before and after 4-month intervention. In addition, at 12-month time point follow-up surveys will be addressed with regard to symptoms and quality of life, as well as to cost-effectiveness of the study.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exercise therapy group
(n = 40)
Home-based exercise
Home-based exercises three times per week.
Knee brace and exercise group
(n = 40)
Home-based exercise
Home-based exercises three times per week.
Knee brace
Progressive use of knee brace each day during activities of daily living.
Footwear device group
(n = 40)
Biomechanical footwear device
Progressive use of footwear each day during activities of daily living.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-based exercise
Home-based exercises three times per week.
Knee brace
Progressive use of knee brace each day during activities of daily living.
Biomechanical footwear device
Progressive use of footwear each day during activities of daily living.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* radiographic knee osteoarthritis (Kellgren-Lawrence grades 1-3)
* age between 45 and 70 years
Exclusion Criteria
* acute (\<6 months) knee trauma
* arthroscopic surgery in the past six months
* a planned knee replacement surgery or other planned surgical treatment of the knee
* knee injections in the past 3 months
* superficial wounds at the knee area
* arterial insufficiency
* severe varicosities
* impaired vision
* postural difficulties
* body-mass index (BMI) \>35kg/m2
* fibromyalgia
* rheumatoid arthritis or other active rheumatoid inflammatory disease.
45 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Finland Hospital District
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jari Ylinen, Ph.D., M.D.
Role: PRINCIPAL_INVESTIGATOR
Central Finland Hospital District
Arja Häkkinen, Ph.D.
Role: STUDY_CHAIR
Central Finland Hospital District
Konsta Pamilo, M.D.
Role: STUDY_CHAIR
Central Finland Hospital District
Ari Heinonen, Ph.D.
Role: STUDY_CHAIR
University of Jyväskylä, Finland
Joost Dekker, Ph.D.
Role: STUDY_CHAIR
VU University Medical Center, Amsterdam, Netherlands
Jari Arokoski, Ph.D, M.D.
Role: STUDY_CHAIR
University of Eastern Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Central Finland Central Hospital
Jyväskylä, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Dnro 11U/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.